Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Meghna A Singhania
    Meghna A Singhania

      Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

      • Home
      • Meghna A Singhania

      Articles By : Meghna A Singhania

      Procedure for approval of FDC drugs: CDSCO releases notification; Details

      Procedure for approval of FDC drugs: CDSCO releases notification; Details

      Meghna A Singhania24 May 2019 6:12 PM IST
      New Delhi: Through a recent notification, the Central Drugs Standard Control Organization (CDSCO) has directed drug manufacturers and all the...
      Fortis investors move SEBI over delay in IHH open offer, ask for interest: Report

      Fortis investors move SEBI over delay in IHH open offer, ask for interest: Report

      Meghna A Singhania23 May 2019 5:22 PM IST
      New Delhi: Displeased with delay in an open offer to buy an additional stake, a few of the shareowners holding minor shares of Fortis Healthcare Ltd...
      CDSCO rejects GSK request to skip Phase III trial for Influenza Vaccine for higher age groups

      CDSCO rejects GSK request to skip Phase III trial for Influenza Vaccine for higher age groups

      Meghna A Singhania22 May 2019 5:25 PM IST
      New Delhi: One of the oldest pharmaceutical and healthcare companies in India, GlaxoSmithKline recently presented before the Subject Expert Committee...
      Drug Alert: CDSCO declares 31 samples as sub-standard in quality in random sampling; Details

      Drug Alert: CDSCO declares 31 samples as sub-standard in quality in random sampling; Details

      Meghna A Singhania21 May 2019 4:44 PM IST
      New Delhi: Apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO) has declared more than a dozen drugs as sub-standard in...
      Red Flag: CDSCO warns against Medtronic pacemaker for battery related malfunction

      Red Flag: CDSCO warns against Medtronic pacemaker for battery related malfunction

      Meghna A Singhania20 May 2019 4:30 PM IST
      New Delhi: Accounting for the safety efficacy, India’s apex drug regulator Central Drugs Standard Control Organisation (CDSCO) has issued an advisory...
      Setback: Delhi HC restricts Natco Pharma from manufacturing cancer drug Ceritinib

      Setback: Delhi HC restricts Natco Pharma from manufacturing cancer drug Ceritinib

      Meghna A Singhania19 May 2019 11:00 AM IST
      New Delhi: In a major setback to the Hyderabad-based Natco Pharma, the Delhi High Court has passed an interim order barring the company from...
      CDSCO releases Risk classification of newly notified Medical Devices, IVDs; Details

      CDSCO releases Risk classification of newly notified Medical Devices, IVDs; Details

      Meghna A Singhania18 May 2019 2:08 PM IST
      New Delhi: Through a recent notification, country's central medical device regulator, the Central Drugs Standards Control Organization (CDSCO) has...
      NPPA strikes again on anti-cancer drug prices; Details

      NPPA strikes again on anti-cancer drug prices; Details

      Meghna A Singhania16 May 2019 4:38 PM IST
      New Delhi: Through a recent Office Memorandum, the National Pharmaceutical Pricing Authority (NPPA) has released an additional list of 9 brands under...
      SEBI asks Fortis to recover Rs 403 crore from Singh Brothers; FHL informs HC

      SEBI asks Fortis to recover Rs 403 crore from Singh Brothers; FHL informs HC

      Meghna A Singhania15 May 2019 12:20 PM IST
      Fortis made the submission in a recent affidavit filed in an ongoing case by Japanese drugmaker Daiichi Sankyo against the Singh brothers and their...
      Improper storage kills shelf life of drugs; Health Ministry raises concern

      Improper storage kills shelf life of drugs; Health Ministry raises concern

      Meghna A Singhania15 May 2019 9:31 AM IST
      As on April 2018, the total sanctioned strength of drug inspectors in the states and Union Territories is about 1,600, out of which about 1,200 drug...
      JnJ baby shampoo free from carcinogenic Formaldehyde; says Gujarat FDCA

      JnJ baby shampoo free from carcinogenic Formaldehyde; says Gujarat FDCA

      Meghna A Singhania10 May 2019 12:40 PM IST
      Ahmedabad: In a major relief, the notable MNC Johnson and Johnson (JnJ) has received clearance from the Gujarat Food and Drugs Control Administration...
      CDSCO officials attend biopharmaceutical industry lobbying group meeting: Objections raised

      CDSCO officials attend biopharmaceutical industry lobbying group meeting: Objections raised

      Meghna A Singhania9 May 2019 1:36 PM IST
      New Delhi: Expressing concern over the participation of senior officials of the national regulatory body Central Drugs Standard Control Organization...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok